Latest filing published 20 Dec 2024 for Corline Biomedical AB, €173k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lars Sunnanvaeder: trading record in brief
Lars Sunnanvaeder discloses dealings in Corline Biomedical AB to Finansinspektionen. Over a trading history stretching from 15 January 2021 to 8 November 2024, the count stands at 3 filings.
Both buying and selling appear: 2 purchases worth €180k, against 1 sale worth €0. Purchases outweigh sales by €180k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: 1 purchase and no sales on the market.
The record was last updated on 20 December 2024 with an open-market purchase (€173k) in Corline Biomedical AB. The median gap between a trade and its publication by Finansinspektionen is 13 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Lars Sunnanvaeder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 333,333 shares@ SEK 6.0096.0% of flowAktieISIN SE0006887451FI:csv-634e5cb005f16ed31315Canonical exit: 6 Feb 2025 (T+90)
- 7,272 shares@ SEK 10.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0015356944FI:csv-38001e3157f0c6f519f1Canonical exit: 22 Apr 2021 (T+90)
- 8 shares@ SEK 0.340.0% of flowTeckningsrätt/UniträttISIN SE0015356936FI:csv-ccf0a9151008dd04d7ea
3 of 3 declarations